Today: 29 April 2026
Hindustan Zinc share price today: HINDZINC stock stays near 52-week high as record silver fuels fresh bull case
23 December 2025
6 mins read

Hindustan Zinc share price today: HINDZINC stock stays near 52-week high as record silver fuels fresh bull case

Hindustan Zinc Limited (NSE: HINDZINC, BSE: 500188) was back in the spotlight on December 23, 2025, with the stock trading in the ₹606–₹615 zone and hovering near fresh 52-week highs after a sharp metals-led run-up this month.

The timing isn’t random. Global precious metals have been on a tear: silver hit a new all-time high near $70/oz while gold pushed to record territory, turbocharging sentiment for companies with meaningful silver exposure—especially Hindustan Zinc, one of India’s most leveraged listed plays on silver prices.

At the same time, broker commentary has turned louder. A bullish initiation from Jefferies with a ₹660 target has become the headline “north star” for momentum traders, even as broader analyst consensus remains more cautious on valuation after the rally. India Today+1

What’s driving Hindustan Zinc stock on Dec 23, 2025

Three forces are doing the heavy lifting:

1) Record silver (and gold) is lifting the entire “precious metals beta” complex
Reuters reported spot silver touched a record $69.98/oz and remained near $69.44/oz early Tuesday, with year-to-date gains topping 141%—outpacing gold. Reuters

That matters because Hindustan Zinc’s earnings mix has steadily shifted: silver is no longer “just a by-product story”—it’s a profit engine.

2) Investors are treating HZL as a clean listed proxy for silver upside
Jefferies explicitly frames Hindustan Zinc as an “attractive way to play” the global silver rally, arguing that even conservative long-range silver price assumptions still leave room for strong cash generation and returns. India Today

3) Metals momentum is broad-based, not a one-stock island
Indian equities were broadly flat in holiday-thinned trading, but sector rotations have kept metals on the bid—helpful context for why dips are being bought quickly in metal-heavy counters.

The silver angle: why it’s not just a price spike story

Hindustan Zinc is India’s top refined zinc producer and a major silver producer; Reuters has described it as the world’s third-largest silver producer and notes India is the world’s biggest silver consumer—both supporting the narrative that domestic and industrial demand can reinforce global pricing cycles.

Jefferies goes further, arguing the company deserves a valuation premium because silver is becoming structurally more important to profitability. In its initiation note, Jefferies says silver contributes about 40% of EBIT, and expects silver’s role in the profit mix to grow further over coming years.

That thesis is echoed in the company’s own commentary: in its FY26 investor communication, Hindustan Zinc highlights that silver drives ~40% of overall profit, underscoring why the market reacts so aggressively to every leg up in silver.

Latest performance snapshot: strong margins and cost discipline

The most recent detailed operating and financial disclosures (FY26 investor materials and Q2 coverage) point to two big investor takeaways: high operating leverage and tight costs.

From Hindustan Zinc’s Q2 FY26 highlights, the company reported (among other metrics):

  • Revenue: ₹8,549 crore
  • EBITDA: ₹4,467 crore
  • Profit after tax: ₹2,649 crore
  • EBITDA margin: 52%
  • Mined metal production: 258 kt (highlighted as best-ever second-quarter mined metal)
  • Zinc cost of production: $994/MT

Reuters’ coverage of the same quarter adds macro color: consolidated net profit rose nearly 14% year-on-year to ₹26.49 billion (₹2,649 crore) and revenue from operations increased to ₹85.49 billion, helped by higher silver prices and steady zinc demand.

The strategic point investors keep circling: when silver rises sharply, Hindustan Zinc’s earnings don’t just “improve”—they can snap upward because much of the operating base is already in place.

Hindustan Zinc forecasts: what guidance and broker models imply

Company guidance for FY26 (production, costs, capex)

In its FY26 outlook, Hindustan Zinc guided to:

  • Mined metal: 1,125 (±10) kt
  • Refined metal: 1,100 (±10) kt
  • Saleable silver: 700–710 MT
  • Zinc cost of production: $1,025–$1,050/MT
  • Growth capex: $225–$250 million

That guidance is the “base case” investors are using to sanity-check whether the current rally is purely price-driven—or also supported by volume/cost improvements.

Jefferies forecast and target price: ₹660 bull case (with conservative commodity assumptions)

Jefferies initiated coverage with a Buy and a ₹660 target, saying the target implies roughly 22% upside including ~4% dividend yield (based on its assumptions at the time).

Key Jefferies projections include:

  • EPS growth: 22% (FY26), 29% (FY27), and 7% (FY28)
  • Estimates described as 9% to 31% higher than consensus forecasts
  • FY27 EV/EBITDA: 9.2x (vs ~7.3x 10-year average cited)
  • Assumed long-range prices (H2 FY26–FY28): zinc $3,225–$3,250/tonne, silver $56–$60/oz (below spot at the time)
  • Forecast annual free cash flow range: ₹8,000–₹14,800 crore

A fun market irony here: Reuters reported spot silver near $69.44/oz on Dec 23, while Jefferies’ modeled silver range is materially lower—so the bull case is explicitly not assuming “spot stays euphoric forever.” Reuters+1

Consensus is cooler: “Hold” bias and lower median target

Not everyone is chasing the breakout at current levels.

A Reuters/Refinitiv snapshot (via LSEG compiled data) noted:

  • Average rating: “Hold” (14 analysts)
  • Median price target: ₹491.50
  • Stock up ~36% YTD at the time of that note

This gap between the Jefferies target and the median target is essentially the market’s debate in one line: is Hindustan Zinc now a “silver-growth compounder,” or still primarily a cyclical with a valuation ceiling?

Expansion and capex: the growth story that could outlast a commodities cycle

Hindustan Zinc isn’t standing still operationally—several projects and approvals are aimed at extending mine life, lifting recoveries, and expanding capacity.

  • New metals complex in Rajasthan: Reuters reported the company approved an expansion project worth ₹120 billion to establish a new metals complex with 250 KT capacity, expected within 36 months, as it aims to double output over time.
  • Zinc tailings reprocessing: The company has also highlighted approval for a 10 MTPA zinc tailings reprocessing plant—a project type investors often like because it can improve resource efficiency and support ESG narratives (though execution and economics still matter).

If these projects deliver on time and within budget, they help justify the argument that Hindustan Zinc’s value is not only “metal price × current capacity,” but also a pipeline of incremental throughput and recovery gains.

Ownership, government stake, and the “Vedanta factor” investors can’t ignore

Hindustan Zinc’s shareholding structure is unusually important for stock-watchers because it can affect supply, sentiment, and headline risk.

As per the company’s shareholding filing for the quarter ended September 30, 2025:

  • Vedanta Limited holds 61.84%
  • President of India account holds 27.92%

Two implications follow:

1) Promoter actions can move the stock
A prior report noted Vedanta planned to sell about 1.6% in Hindustan Zinc via block deals to raise roughly ₹3,018 crore (headline risk for price discovery when supply hits).

2) Promoter encumbrance is a real risk variable
The same shareholding disclosure indicates promoter shares are pledged/otherwise encumbered at significant levels (a datapoint also flagged by market screeners). High encumbrance doesn’t automatically mean distress, but markets tend to assign it a risk premium because it can amplify volatility during promoter funding events.

Separately, the Vedanta ecosystem itself is in motion: Reuters reported India’s tribunal cleared Vedanta’s demerger plan, targeting completion by March 31, 2026. That’s not directly “a Hindustan Zinc event,” but it can influence sentiment around promoter leverage and strategic optionality. Reuters

Technical view: momentum is strong, but “buy-the-dip” is replacing “buy-anything”

Technicians have been highlighting Hindustan Zinc’s breakout behavior after a multi-month consolidation, with short-term targets being discussed above ₹600 and a preference to accumulate on pullbacks rather than chase vertical candles.

This matches the feel of the tape on Dec 23: the stock isn’t exploding every hour, but it’s holding gains close to highs—often what strong trends do before they either continue… or finally run out of oxygen.

Key risks investors are weighing right now

Even with the silver narrative firing on all cylinders, this is still a mining-and-metals stock, meaning risk comes bundled with the opportunity:

  • Commodity risk: Silver and zinc can fall hard and fast; even Reuters flagged thinner year-end liquidity potentially amplifying price swings.
  • Valuation risk: Jefferies itself acknowledges a premium valuation versus historical averages, arguing it’s justified by silver mix—others disagree, and consensus targets reflect that split.
  • Execution risk: Expansions (new complex, reprocessing plants) create upside, but delays and cost overruns can dent the story.
  • Promoter/ownership overhang: Pledges/encumbrances and potential stake sales can pressure sentiment regardless of operating performance.

What to watch next after Dec 23

For the next few weeks, Hindustan Zinc investors are likely tracking five “live wires”:

  1. Silver price direction after hitting records (does it consolidate, or trend higher again?)
  2. Management commentary on costs and FY26 delivery vs guidance
  3. Update cadence on big capex projects (timelines, funding mix, returns)
  4. Promoter headlines (stake sale chatter, encumbrance changes, group restructuring developments)
  5. The Q3 earnings runway—even Reuters noted markets are looking toward the upcoming earnings season for confirmation of profit momentum.

Bottom line

As of December 23, 2025, Hindustan Zinc stock is behaving like a textbook “macro + fundamentals” momentum name: record silver prices are powering sentiment, recent margins and cost performance support the narrative, and Jefferies has put a prominent ₹660 marker on the upside debate. Reuters+2Hindustan Zinc+2

But the market isn’t unanimous. LSEG-compiled consensus still skews Hold with a much lower median target—signaling that at least part of the street believes a lot of good news is already in the price.

In other words: Hindustan Zinc is currently a battleground between “silver is structural” and “cycles always humble optimism.” The next act will be written by the metal prices, execution on capacity/cost, and how cleanly the ownership overhang stays out of the way.

Stock Market Today

  • Biotech with $277M Cash Says It Can Fund Operations Through 2028
    April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies, essential for market approval and revenue potential. Its financial position is underpinned by regulatory filings, including registration statements on Form S-1, offering transparency for investors assessing risks and opportunities. This solid cash reserve and regulatory progress support confidence in sustained operations and developmental goals over the coming years.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 29.04.2026

29 April 2026
LIVEMarkets rolling coverageStarted: April 29, 2026, 12:00 AM EDTUpdated: April 29, 2026, 2:59 AM EDT Biotech with $277M Cash Says It Can Fund Operations Through 2028 April 29, 2026, 2:48 AM EDT. A biotech company reports having $277 million in cash, stating it can finance its operations through 2028. The firm highlights progress in regulatory milestones, including orphan drug designation and fast track status, which aim to expedite drug approvals for rare diseases. These designations often provide special incentives and faster review processes. The company is advancing clinical trials with key drugs in Phase 2b and planning Phase 3 studies,
AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
Meesho Limited Share Price Today (23 December 2025): MEESHO Stock Extends Sell-Off After Post-IPO Surge—Latest News, Analyst Targets, and Outlook
Previous Story

Meesho Limited Share Price Today (23 December 2025): MEESHO Stock Extends Sell-Off After Post-IPO Surge—Latest News, Analyst Targets, and Outlook

Tata Motors Stock Surges on Dec. 23, 2025: Why TMCV Shares Are Rising, What Brokerages Forecast, and the Iveco Deal Risks to Watch
Next Story

Tata Motors Stock Surges on Dec. 23, 2025: Why TMCV Shares Are Rising, What Brokerages Forecast, and the Iveco Deal Risks to Watch

Go toTop